Extended Data Table 5 Summary of arithmetic means (s.d.) of PK parameters after first dose of cadonilimab in combination with chemotherapy

From: Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial

  1. Tmax was reported as the median (minimum, maximum).
  2. AUC0–t, area under the serum concentration-time curve from 0 h to the last measurable concentration; AUC0–∞, area under the serum concentration-time curve post-dose 0–∞ h; CL, clearance; Cmax, maximum concentration; t1/2, elimination half-life; Tmax, time to maximum concentration; Vd, apparent volume of distribution.
Back to article page